State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, College of Chemistry and Pharmacy, Guangxi Normal University, Guilin, 541004, China.
Nanoscale. 2016 May 19;8(20):10814-22. doi: 10.1039/c6nr02725c.
In this work, we report a reducing agent-free strategy for the synthesis of Fe3O4 nanoparticle/nitrogen-doped graphene quantum dot (Fe3O4/N-GQD) hybrids, and constructed a sensing platform based on Fe3O4/N-GQDs for the visual discrimination of phenylenediamine isomers. Fe3O4/N-GQDs were facilely prepared by hydrothermal treatment of Fe(3+)/N-GQD solutions under alkaline conditions without other reagents. The prepared Fe3O4/N-GQDs exhibited outstanding peroxidase-like activity and were stable under a wide range of pH values and temperatures. The phenylenediamine isomers (o-phenylenediamine, m-phenylenediamine, and p-phenylenediamine) were discriminated through the H2O2-mediated oxidation reaction using Fe3O4/N-GQDs as novel peroxidase mimics, which resulted in appreciable color changes. The proposed method is simple, economical, and effective for discrimination of isomers, and can be used for sensitive and selective quantitative analysis of o-phenylenediamine and p-phenylenediamine. A good linear relationship from 1 to 90 μM and a detection limit of 230 nM for o-phenylenediamine were achieved, and the linear relationship for p-phenylenediamine was from 2 to 70 μM with a detection limit of 530 nM. The proposed method may open new applications of Fe3O4/N-GQDs in biomedicine and environmental chemistry.
在这项工作中,我们报告了一种无还原剂策略,用于合成 Fe3O4 纳米颗粒/氮掺杂石墨烯量子点(Fe3O4/N-GQD)杂化物,并基于 Fe3O4/N-GQDs 构建了一个传感平台,用于对苯二胺异构体的可视化区分。通过在碱性条件下将 Fe(3+)/N-GQD 溶液水热处理,无需其他试剂即可轻松制备 Fe3O4/N-GQDs。所制备的 Fe3O4/N-GQDs 表现出优异的过氧化物酶样活性,并且在广泛的 pH 值和温度范围内稳定。通过使用 Fe3O4/N-GQDs 作为新型过氧化物酶模拟物,通过 H2O2 介导的氧化反应来区分苯二胺异构体(邻苯二胺、间苯二胺和对苯二胺),导致明显的颜色变化。该方法简单、经济、有效,可用于异构体的区分,并可用于对邻苯二胺和对苯二胺进行灵敏和选择性定量分析。对邻苯二胺的线性关系从 1 到 90 μM,检测限为 230 nM,对苯二胺的线性关系从 2 到 70 μM,检测限为 530 nM。该方法可能为 Fe3O4/N-GQDs 在生物医学和环境化学中的应用开辟新的途径。
ACS Appl Mater Interfaces. 2017-12-22
Front Bioeng Biotechnol. 2023-3-2